NZ Trader - given the sensitivities for Parkinsons sufferers the company won't be talking up the potential of NTCell pre unblinding. Id suggest they are purposely not entertaining any PR or IR ....yet!!
The register is approx. 70% owned by ultra wealthy individuals. This will put the company in good stead to not entertain opportunists in the early stages post successful results. If you use AstraZeneca Takeda deal valued at $800m as a bench mark....Fresh air through to $500m+ valuation.
NZ Trader - given the sensitivities for Parkinsons sufferers the...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $16.87M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.3¢ | 1.0¢ | $372.1K | 31.96M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 3270828 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1370000 | 6 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |